Clinical Trial Update: Fengliao Changweikang for Diarrhea-predominant Irritable Bowel Syndrome: N-of-1 Trial [Phase 4]

View source ↗

Summary

This clinical trial update describes an N-of-1, Phase 4 study of Fengliao Changweikang for diarrhea-predominant irritable bowel syndrome, with the trial current…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome

Drugs mentioned

• Fengliao Changweikang

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Irritable Bowel Syndrome - Diarrhoea, Traditional Chinese Medicine (TCM) | Phase 4 | Status: NOT_YET_RECRUITING